News

    Publications

     

    2021

    • Schmelter C, Fomo KN, Perumal N, Pfeiffer N, Grus FH (2021) Regulation of the HTRA2 Protease Activity by an Inhibitory Antibody-Derived Peptide Ligand and the Influence on HTRA2-Specific Protein Interaction Networks in Retinal Tissues. Biomedicines 9. https://www.mdpi.com/2227-9059/9/8/1013

    • Beutgen VM, Schmelter C, Pfeiffer N, Grus FH (2021) Contribution of the Commensal Microflora to the Immunological Homeostasis and the Importance of Immune-Related Drug Development for Clinical Applications. International journal of molecular sciences 22. https://www.mdpi.com/1422-0067/22/16/8896

    • Beutgen VM, Pfeiffer N, Grus FH (2021) Serological Levels of Anti-clathrin Antibodies Are Decreased in Patients With Pseudoexfoliation Glaucoma. Frontiers in immunology 12:616421. https://www.frontiersin.org/articles/10.3389/fimmu.2021.616421/full

    • Jiong Hu, Marco Sisignano, Roman Brecht, Natarajan Perumal, Carlo Angioni, Iris-Sofia Bibli, Beate Fisslthaler, Hartmut Kleinert, Norbert Pfeiffer, Ingrid Fleming and Caroline Manicam (2021). Cyp2c44 epoxygenase-derived epoxyeicosatrienoic acids in vascular smooth muscle cells elicit vasoconstriction of the murine ophthalmic artery. Scientific Reports 11, 18764. https://doi.org/10.1038/s41598-021-98236-w.
    • David P. Herzog*, Natarajan Perumal*, Caroline Manicam, Giulia Treccani, Jens Nadig, Milena Rossmanith, Jan Engelmann, Tanja Jene, Annika Hasch, Michael A. van der Kooij, Klaus Lieb, Nils C. Gassen, Franz H. Grus and Marianne B. Müller (2021). Longitudinal CSF proteome profiling in mice to uncover the acute and sustained mechanisms of action of rapid acting antidepressant (2R,6R)-hydroxynorketamine (HNK). Neurobiology of Stress 15: 100404. https://doi.org/10.1016/j.ynstr.2021.100404. *shared first authorship

     

    2020

    • Reinehr, S., et al., Occurrence of Retinal Ganglion Cell Loss via Autophagy and Apoptotic Pathways in an Autoimmune Glaucoma Model. Current eye research, 2020: p. 1-12.
    • Perumal, N., et al., Bioenergetic shift and actin cytoskeleton remodelling as acute vascular adaptive mechanisms to angiotensin II in murine retina and ophthalmic artery. Redox biology, 2020: p. 101597.
    • Liu, H., et al., Proteome alterations in aqueous humour of primary open angle glaucoma patients. International journal of ophthalmology, 2020. 13(1): p. 176-179.
    • Grotegut, P., et al., Minocycline reduces inflammatory response and cell death in a S100B retina degeneration model. Journal of neuroinflammation, 2020. 17(1): p. 375.
    • Beutgen, V.M., et al., Autoantigens in the trabecular meshwork and glaucoma-specific alterations in the natural autoantibody repertoire. Clinical & translational immunology, 2020. 9(3): p. e01101.
    • Bell, K., et al., Age related retinal Ganglion cell susceptibility in context of autophagy deficiency. Cell death discovery, 2020. 6: p. 21.
    • Bell, K., et al., Results from the Population-Based Gutenberg Health Study Revealing Four Altered Autoantibodies in Retinal Vein Occlusion Patients. Journal of ophthalmology, 2020. 2020: p. 8386160.

     

    2019

    • Wiesmann, N., et al., Phosphoproteome Profiling Reveals Multifunctional Protein NPM1 as part of the Irradiation Response of Tumor Cells. Transl Oncol, 2019. 12(2): p. 308-319.
    • Schmelter, C., et al., Synthetic Polyclonal-Derived CDR Peptides as an Innovative Strategy in Glaucoma Therapy. J Clin Med, 2019. 8(8).
    • Perumal, N., et al., Sample Preparation for Mass-spectrometry-based Proteomics Analysis of Ocular Microvessels. J Vis Exp, 2019(144).
    • Mann, C., et al., [Endothelial Cell Reaction to Elevated Hydrostatic Pressure and Oxidative Stress in Vitro]. Klin Monbl Augenheilkd, 2019. 236(9): p. 1122-1128.
    • Mann, C., et al., [Morphological and Quantitative Changes in Retinal and Optic Nerve Vessels in Experimental Glaucoma Model with Elevated IOP for 7 Weeks]. Klin Monbl Augenheilkd, 2019. 236(7): p. 871-876.
    • Lauzi, J., et al., Neuroprotective and neuroregenerative effects of CRMP-5 on retinal ganglion cells in an experimental in vivo and in vitro model of glaucoma. PLoS One, 2019. 14(1): p. e0207190.
    • Hampel, U., et al., Relaxin 2 fails to lower intraocular pressure and to dilate retinal vessels in rats. Int Ophthalmol, 2019. 39(4): p. 847-851.
    • Haller, N., et al., Circulating, Cell-Free DNA for Monitoring Player Load in Professional Football. Int J Sports Physiol Perform, 2019. 14(6): p. 718-726.
    • Grus, F., [Glaucoma beyond intraocular pressure : New approaches]. Ophthalmologe, 2019. 116(1): p. 4.
    • Funke, S., et al., Comparative Quantitative Analysis of Porcine Optic Nerve Head and Retina Subproteomes. Int J Mol Sci, 2019. 20(17).
    • Funke, S., et al., An In-Depth View of the Porcine Trabecular Meshwork Proteome. Int J Mol Sci, 2019. 20(10).
    • Chrysostomou, V., et al., [Visual recovery as the target for glaucoma]. Ophthalmologe, 2019. 116(1): p. 14-17.
    • Christ, M.G., et al., Sigma-1 Receptor Activation Induces Autophagy and Increases Proteostasis Capacity In Vitro and In Vivo. Cells, 2019. 8(3).
    • Chakraborty, D., et al., Enhanced autophagic-lysosomal activity and increased BAG3-mediated selective macroautophagy as adaptive response of neuronal cells to chronic oxidative stress. Redox Biol, 2019. 24: p. 101181.
    • Boerger, M., et al., Proteomic analysis of tear fluid reveals disease-specific patterns in patients with Parkinson's disease - A pilot study. Parkinsonism Relat Disord, 2019. 63: p. 3-9.
    • Beutgen, V.M., et al., Autoantibody Biomarker Discovery in Primary Open Angle Glaucoma Using Serological Proteome Analysis (SERPA). Front Immunol, 2019. 10: p. 381.
    • Bell, K., S. Funke, and F.H. Grus, [Autoimmunity and glaucoma]. Ophthalmologe, 2019. 116(1): p. 18-27.

     

    2018

    • Wessbecher, I.M., et al., DNA mismatch repair activity of MutLalpha is regulated by CK2-dependent phosphorylation of MLH1 (S477). Mol Carcinog, 2018. 57(12): p. 1723-1734.
    • Teister, J., et al., Peripapillary fluorescence lifetime reveals age-dependent changes using fluorescence lifetime imaging ophthalmoscopy in rats. Exp Eye Res, 2018. 176: p. 110-120.
    • Schmelter, C., et al., Comparison of Two Solid-Phase Extraction (SPE) Methods for the Identification and Quantification of Porcine Retinal Protein Markers by LC-MS/MS. Int J Mol Sci, 2018. 19(12).
    • Mann, C., et al., [Endothelial Cell Reaction to Elevated Hydrostatic Pressure and Oxidative Stress in Vitro]. Klin Monbl Augenheilkd, 2018.
    • Mann, C., et al., [Morphological and Quantitative Changes in Retinal and Optic Nerve Vessels in Experimental Glaucoma Model with Elevated IOP for 7 Weeks]. Klin Monbl Augenheilkd, 2018.
    • Manicam, C., et al., Proteomics Unravels the Regulatory Mechanisms in Human Tears Following Acute Renouncement of Contact Lens Use: A Comparison between Hard and Soft Lenses. Sci Rep, 2018. 8(1): p. 11526.
    • Haller, N., et al., Circulation, Cell-free DNA for Monitoring Player Load in Professional Football. Int J Sports Physiol Perform, 2018: p. 1-27.
    • Bell, K., et al., Modulation of the Immune System for the Treatment of Glaucoma. Curr Neuropharmacol, 2018. 16(7): p. 942-958.

     

    2017

    • Von Thun Und Hohenstein-Blaul, N., et al., Biomarkers for glaucoma: from the lab to the clinic. Eye (Lond), 2017. 31(2): p. 225-231.
    • Teister, J., et al., Decelerated neurodegeneration after intravitreal injection of alpha-synuclein antibodies in a glaucoma animal model. Sci Rep, 2017. 7(1): p. 6260.
    • Schmelter, C., et al., Peptides of the variable IgG domain as potential biomarker candidates in primary open-angle glaucoma (POAG). Hum Mol Genet, 2017. 26(22): p. 4451-4464.
    • Perumal, N., et al., Characterization of the human aqueous humour proteome: A comparison of the genders. PLoS One, 2017. 12(3): p. e0172481.
    • Lorenz, K., et al., A prospective, randomised, placebo-controlled, double-masked, three-armed, multicentre phase II/III trial for the Study of a Topical Treatment of Ischaemic Central Retinal Vein Occlusion to Prevent Neovascular Glaucoma - the STRONG study: study protocol for a randomised controlled trial. Trials, 2017. 18(1): p. 128.
    • Lorenz, K., et al., Course of serum autoantibodies in patients after acute angle-closure glaucoma attack. Clin Exp Ophthalmol, 2017. 45(3): p. 280-287.
    • Liu, H., et al., Hydrogen Sulfide Protects Retinal Ganglion Cells Against Glaucomatous Injury In Vitro and In Vivo. Invest Ophthalmol Vis Sci, 2017. 58(12): p. 5129-5141.
    • Laspas, P., et al., Revision of encapsulated blebs after trabeculectomy: Long-term comparison of standard bleb needling and modified needling procedure combined with transconjunctival scleral flap sutures. PLoS One, 2017. 12(5): p. e0178099.
    • Funke, S., et al., The potential impact of recent insights into proteomic changes associated with glaucoma. Expert Rev Proteomics, 2017. 14(4): p. 311-334.
    • Funke, S., et al., In-Depth Proteomic Analysis of the Porcine Retina by Use of a four Step Differential Extraction Bottom up LC MS Platform. Mol Neurobiol, 2017. 54(9): p. 7262-7275.
    • Bell, K., et al., Elevated Regulatory T Cell Levels in Glaucoma Patients in Comparison to Healthy Controls. Curr Eye Res, 2017. 42(4): p. 562-567.
    • Anders, F., et al., Intravitreal injection of beta-crystallin B2 improves retinal ganglion cell survival in an experimental animal model of glaucoma. PLoS One, 2017. 12(4): p. e0175451.
    • Anders, F., et al., Proteomic profiling reveals crucial retinal protein alterations in the early phase of an experimental glaucoma model. Graefes Arch Clin Exp Ophthalmol, 2017. 255(7): p. 1395-1407.
    • Anders, F., et al., The Small Heat Shock Protein alpha-Crystallin B Shows Neuroprotective Properties in a Glaucoma Animal Model. Int J Mol Sci, 2017. 18(11).

     

    2016

    1. Von Thun Und Hohenstein-Blaul, N., et al., Autoimmune aspects in glaucoma. Eur J Pharmacol, 2016. 787: p. 105-18.
    2. Perumal, N., et al., Proteomics analysis of human tears from aqueous-deficient and evaporative dry eye patients. Sci Rep, 2016. 6: p. 29629.
    3. Manicam, C., et al., The Gatekeepers in the Mouse Ophthalmic Artery: Endothelium-Dependent Mechanisms of Cholinergic Vasodilation. Sci Rep, 2016. 6: p. 20322.
    4. Manicam, C., et al., First insight into the proteome landscape of the porcine short posterior ciliary arteries: Key signalling pathways maintaining physiologic functions. Sci Rep, 2016. 6: p. 38298.
    5. Lorenz, K., et al., Longitudinal Analysis of Serum Autoantibody-Reactivities in Patients with Primary Open Angle Glaucoma and Optic Disc Hemorrhage. PLoS One, 2016. 11(12): p. e0166813.
    6. Laspas, P., et al., A New Method for Revision of Encapsulated Blebs after Trabeculectomy: Combination of Standard Bleb Needling with Transconjunctival Scleral Flap Sutures Prevents Early Postoperative Hypotony. PLoS One, 2016. 11(6): p. e0157320.
    7. Gramlich, O.W., et al., Immune response after intermittent minimally invasive intraocular pressure elevations in an experimental animal model of glaucoma. J Neuroinflammation, 2016. 13(1): p. 82.
    8. Funke, S., et al., Glaucoma related Proteomic Alterations in Human Retina Samples. Sci Rep, 2016. 6: p. 29759.
    9. Funke, S., et al., Analysis of the effects of preservative-free tafluprost on the tear proteome. Am J Transl Res, 2016. 8(10): p. 4025-4039.
    10. Bell, K., et al., Neuroprotective effects of antibodies on retinal ganglion cells in an adolescent retina organ culture. J Neurochem, 2016. 139(2): p. 256-269.

     

    2015

    • Wilding, C., et al., GFAP antibodies show protective effect on oxidatively stressed neuroretinal cells via interaction with ERP57. J Pharmacol Sci, 2015. 127(3): p. 298-304.
    • von Thun und Hohenstein-Blaul, N., et al., [Basic biochemical processes in glaucoma progression]. Ophthalmologe, 2015. 112(5): p. 395-401.
    • Strozynski, J., et al., Proteomic identification of the heterogeneous nuclear ribonucleoprotein K as irradiation responsive protein related to migration. J Proteomics, 2015. 113: p. 154-61.
    • Perumal, N., et al., Characterization of human reflex tear proteome reveals high expression of lacrimal proline-rich protein 4 (PRR4). Proteomics, 2015. 15(19): p. 3370-81.
    • Matheis, N., et al., Proteomics of Orbital Tissue in Thyroid-Associated Orbitopathy. J Clin Endocrinol Metab, 2015. 100(12): p. E1523-30.
    • Matheis, N., et al., Proteomics Differentiate Between Thyroid-Associated Orbitopathy and Dry Eye Syndrome. Invest Ophthalmol Vis Sci, 2015. 56(4): p. 2649-56.
    • Laspas, P., et al., Effect of the M1 Muscarinic Acetylcholine Receptor on Retinal Neuron Number Studied with Gene-Targeted Mice. J Mol Neurosci, 2015. 56(2): p. 472-9.
    • Casola, C., et al., S100 alone has the same destructive effect on retinal ganglion cells as in combination with HSP 27 in an autoimmune glaucoma model. J Mol Neurosci, 2015. 56(1): p. 228-36.
    • Bell, K., et al., Protective effect of 14-3-3 antibodies on stressed neuroretinal cells via the mitochondrial apoptosis pathway. BMC Ophthalmol, 2015. 15: p. 64.

     

    2014

    • Wilding, C., et al., gamma-Synuclein antibodies have neuroprotective potential on neuroretinal cells via proteins of the mitochondrial apoptosis pathway. PLoS One, 2014. 9(3): p. e90737.
    • Perumal, N., et al., Characterization of lacrimal proline-rich protein 4 (PRR4) in human tear proteome. Proteomics, 2014. 14(13-14): p. 1698-709.
    • Manicam, C., et al., Effective melanin depigmentation of human and murine ocular tissues: an improved method for paraffin and frozen sections. PLoS One, 2014. 9(7): p. e102512.
    • Lorenz, K., et al., Series of fibrinous inflammation after implantation of capsular tension rings. J Cataract Refract Surg, 2014. 40(2): p. 192-8.
    • Joachim, S.C., et al., Apoptotic retinal ganglion cell death in an autoimmune glaucoma model is accompanied by antibody depositions. J Mol Neurosci, 2014. 52(2): p. 216-24.
    • Gramlich, O.W., et al., Dynamics, alterations, and consequences of minimally invasive intraocular pressure elevation in rats. Invest Ophthalmol Vis Sci, 2014. 55(1): p. 600-11.
    • Gramlich, O.W., et al., Catestatin-like immunoreactivity in the rat eye. Neuropeptides, 2014. 48(1): p. 7-13.
    • Bell, K., N. Pfeiffer, and F.H. Grus, [Pharmacokinetics of the anterior eye]. Ophthalmologe, 2014. 111(2): p. 107-12.

     

    2013

    • von Thun Und Hohenstein-Blaul, N., S. Funke, and F.H. Grus, Tears as a source of biomarkers for ocular and systemic diseases. Exp Eye Res, 2013. 117: p. 126-37.
    • Pfeiffer, N., et al., Neuroprotection of medical IOP-lowering therapy. Cell Tissue Res, 2013. 353(2): p. 245-51.
    • Lu, Y., et al., Genome-wide association analyses identify multiple loci associated with central corneal thickness and keratoconus. Nat Genet, 2013. 45(2): p. 155-63.
    • Korb, C., et al., Serum protein analysis of patients with different vitreoretinal diseases by means of antibody microarrays. Investigative Ophthalmology & Visual Science, 2013. 54(15): p. 3332-3332.
    • Joachim, S.C., et al., Immune response against ocular tissues after immunization with optic nerve antigens in a model of autoimmune glaucoma. Mol Vis, 2013. 19: p. 1804-14.
    • Gramlich, O.W., et al., Autoimmune biomarkers in glaucoma patients. Curr Opin Pharmacol, 2013. 13(1): p. 90-7.
    • Gramlich, O.W., et al., Enhanced insight into the autoimmune component of glaucoma: IgG autoantibody accumulation and pro-inflammatory conditions in human glaucomatous retina. PLoS One, 2013. 8(2): p. e57557.
    • Boehm, N., et al., Alterations in the tear proteome of dry eye patients--a matter of the clinical phenotype. Invest Ophthalmol Vis Sci, 2013. 54(3): p. 2385-92.
    • Bhattacharya, S.K., et al., Molecular biomarkers in glaucoma. Invest Ophthalmol Vis Sci, 2013. 54(1): p. 121-31.
    • Bell, K., et al., Does autoimmunity play a part in the pathogenesis of glaucoma? Prog Retin Eye Res, 2013. 36: p. 199-216.

     

    2012

    • Matheis, N., et al., Proteomics of tear fluid in thyroid-associated orbitopathy. Thyroid, 2012. 22(10): p. 1039-45.
    • Lorenz, K., et al., GE-25-like immunoreactivity in the rat eye. Peptides, 2012. 36(2): p. 286-91.
    • Korb, C.A., et al., Intraindividual Proteomic Comparison of Human Tears and Vitreous in Patients With Different Vitreoretinal Diseases by Means of Antibody Microarrays. Investigative Ophthalmology & Visual Science, 2012. 53(14): p. 888-888.
    • Joachim, S.C., et al., Effect of ischemia duration on autoantibody response in rats undergoing retinal ischemia-reperfusion. Ophthalmic Res, 2012. 48(2): p. 67-74.
    • Joachim, S.C., et al., Retinal ganglion cell loss is accompanied by antibody depositions and increased levels of microglia after immunization with retinal antigens. PLoS One, 2012. 7(7): p. e40616.
    • Hohenstein-Blaul, N.v.T.u., et al., Proteomic Analysis of Tears in Patients with Various Ocular Diseases using Antibody Microarrays. Investigative Ophthalmology & Visual Science, 2012. 53(14): p. 4238-4238.
    • Hoehn, R., et al., Population-based meta-analysis in Caucasians confirms association with COL5A1 and ZNF469 but not COL8A2 with central corneal thickness. Hum Genet, 2012. 131(11): p. 1783-93.
    • Funke, S., et al., Longitudinal analysis of taurine induced effects on the tear proteome of contact lens wearers and dry eye patients using a RP-RP-Capillary-HPLC-MALDI TOF/TOF MS approach. J Proteomics, 2012. 75(11): p. 3177-90.
    • Bohm, D., et al., Comparison of tear protein levels in breast cancer patients and healthy controls using a de novo proteomic approach. Oncol Rep, 2012. 28(2): p. 429-38.
    • Boehm, N., et al., New insights into autoantibody profiles from immune privileged sites in the eye: a glaucoma study. Brain Behav Immun, 2012. 26(1): p. 96-102.
    • Bell, K., et al., Serum and antibodies of glaucoma patients lead to changes in the proteome, especially cell regulatory proteins, in retinal cells. PLoS One, 2012. 7(10): p. e46910.
    • Bell, K., et al., Comparison of the effects of different lens-cleaning solutions on the protein profiles of human conjunctival cells. Graefes Arch Clin Exp Ophthalmol, 2012. 250(11): p. 1627-36.

     

    2011

    • Weis, E., et al., Reduced mRNA and protein expression of the genomic caretaker RAD9A in primary fibroblasts of individuals with childhood and independent second cancer. PLoS One, 2011. 6(10): p. e25750.
    • Thiel, U.J., et al., Analysis of differentially expressed proteins in oral squamous cell carcinoma by MALDI-TOF MS. J Oral Pathol Med, 2011. 40(5): p. 369-79.
    • Lorenz, K., et al., PE-11, a peptide derived from chromogranin B, in the rat eye. Peptides, 2011. 32(6): p. 1201-6.
    • Laspas, P., et al., Autoreactive antibodies and loss of retinal ganglion cells in rats induced by immunization with ocular antigens. Invest Ophthalmol Vis Sci, 2011. 52(12): p. 8835-48.
    • Kramann, C., et al., Effect of contact lenses on the protein composition in tear film: a ProteinChip study. Graefes Arch Clin Exp Ophthalmol, 2011. 249(2): p. 233-43.
    • Joachim, S.C., et al., Upregulation of antibody response to heat shock proteins and tissue antigens in an ocular ischemia model. Invest Ophthalmol Vis Sci, 2011. 52(6): p. 3468-74.
    • Grus, F.H. and O.W. Gramlich, [Autoimmunity and glaucoma]. Klin Monbl Augenheilkd, 2011. 228(5): p. 439-45.
    • Gramlich, O.W., et al., Ophthalmopathology in rats with MBP-induced experimental autoimmune encephalomyelitis. Graefes Arch Clin Exp Ophthalmol, 2011. 249(7): p. 1009-20.
    • Gericke, A., et al., Identification of the muscarinic acetylcholine receptor subtype mediating cholinergic vasodilation in murine retinal arterioles. Invest Ophthalmol Vis Sci, 2011. 52(10): p. 7479-84.
    • Bohm, D., et al., Serum proteome profiling of primary breast cancer indicates a specific biomarker profile. Oncol Rep, 2011. 26(5): p. 1051-6.
    • Bohm, D., et al., Antibody microarray analysis of the serum proteome in primary breast cancer patients. Cancer Biol Ther, 2011. 12(9): p. 772-9.
    • Boehm, N., et al., Proinflammatory cytokine profiling of tears from dry eye patients by means of antibody microarrays. Invest Ophthalmol Vis Sci, 2011. 52(10): p. 7725-30.

     

    2010

    • Joachim, S.C., et al., Enhanced characterization of serum autoantibody reactivity following HSP 60 immunization in a rat model of experimental autoimmune glaucoma. Curr Eye Res, 2010. 35(10): p. 900-8.
    • Grus, F.H., [Relationship between oxidatve stress and autoimmunity in glaucoma]. Klin Monbl Augenheilkd, 2010. 227(2): p. 114-9.
    • Cuny, C.S., et al., Repeated intraocular pressure measurement in awake Lewis rats does not bias retinal ganglion cell survival. Curr Eye Res, 2010. 35(11): p. 1034-9.

     

    2009

    • Okrojek, R., et al., Proteomics in autoimmune thyroid eye disease. Horm Metab Res, 2009. 41(6): p. 465-70.
    • Lebrecht, A., et al., Diagnosis of breast cancer by tear proteomic pattern. Cancer Genomics Proteomics, 2009. 6(3): p. 177-82.
    • Lebrecht, A., et al., Surface-enhanced Laser Desorption/Ionisation Time-of-flight Mass Spectrometry to Detect Breast Cancer Markers in Tears and Serum. Cancer Genomics Proteomics, 2009. 6(2): p. 75-83.
    • Kramann, C.A., et al., Proteomic Analysis of Tears in Patients With Dry and Exsudative Age-Related Macular Degeneration. Investigative Ophthalmology & Visual Science, 2009. 50(13): p. 737-737.
    • Joachim, S.C., et al., Complex antibody profile changes in an experimental autoimmune glaucoma animal model. Invest Ophthalmol Vis Sci, 2009. 50(10): p. 4734-42.
    • Gericke, A., et al., Cholinergic responses of ophthalmic arteries in M3 and M5 muscarinic acetylcholine receptor knockout mice. Invest Ophthalmol Vis Sci, 2009. 50(10): p. 4822-7.

     

    2008

    • Reichelt, J., et al., Analysis of autoantibodies against human retinal antigens in sera of patients with glaucoma and ocular hypertension. Curr Eye Res, 2008. 33(3): p. 253-61.
    • Joachim, S.C., et al., Sera of glaucoma patients show autoantibodies against myelin basic protein and complex autoantibody profiles against human optic nerve antigens. Graefes Arch Clin Exp Ophthalmol, 2008. 246(4): p. 573-80.
    • Grus, F.H., et al., Autoimmunity and glaucoma. J Glaucoma, 2008. 17(1): p. 79-84.
    • Grus, F.H., et al., Transthyretin and complex protein pattern in aqueous humor of patients with primary open-angle glaucoma. Mol Vis, 2008. 14: p. 1437-45.
    • Grus, F. and D. Sun, Immunological mechanisms in glaucoma. Semin Immunopathol, 2008. 30(2): p. 121-6.
    • Geerling, G., et al., [Legal regulations to produce serum eye drops : when is it necessary, and how can it be obtained?]. Ophthalmologe, 2008. 105(7): p. 632-8.
    • Brust, A.K., et al., Effects of Cyclooxygenase Inhibitors on Apoptotic Neuroretinal Cells. Biomark Insights, 2008. 3: p. 387-402.

     

    2007

    • Joachim, S.C., et al., IgG antibody patterns in aqueous humor of patients with primary open angle glaucoma and pseudoexfoliation glaucoma. Mol Vis, 2007. 13: p. 1573-9.
    • Joachim, S.C., et al., Analysis of IgG antibody patterns against retinal antigens and antibodies to alpha-crystallin, GFAP, and alpha-enolase in sera of patients with "wet" age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol, 2007. 245(5): p. 619-26.
    • Joachim, S.C., et al., Antibodies to alpha B-crystallin, vimentin, and heat shock protein 70 in aqueous humor of patients with normal tension glaucoma and IgG antibody patterns against retinal antigen in aqueous humor. Curr Eye Res, 2007. 32(6): p. 501-9.
    • Grus, F.H., S.C. Joachim, and N. Pfeiffer, Proteomics in ocular fluids. Proteomics Clin Appl, 2007. 1(8): p. 876-88.

     

    2006

    • Hoffmann, E.M., et al., [Goldmann applanation tonometry and dynamic contour tonometry. Comparison of intraocular pressure measurements in the course of product certification according to EN ISO 8612:2001]. Ophthalmologe, 2006. 103(4): p. 317-20.
    • Hoffmann, E.M., et al., Repeatability and reproducibility of optic nerve head topography using the retinal thickness analyzer. Graefes Arch Clin Exp Ophthalmol, 2006. 244(2): p. 192-8.
    • Hoffmann, E.M., et al., Glaucoma detection using the GDx nerve fiber analyzer and the retinal thickness analyzer (RTA). Eur J Ophthalmol, 2006. 16(2): p. 251-8.
    • Grus, F.H., et al., Serum autoantibodies to alpha-fodrin are present in glaucoma patients from Germany and the United States. Invest Ophthalmol Vis Sci, 2006. 47(3): p. 968-76.
    • Barleon, L., et al., Comparison of dynamic contour tonometry and goldmann applanation tonometry in glaucoma patients and healthy subjects. Am J Ophthalmol, 2006. 142(4): p. 583-90.

     

    2005

    • Joachim, S.C., N. Pfeiffer, and F.H. Grus, Autoantibodies in patients with glaucoma: a comparison of IgG serum antibodies against retinal, optic nerve, and optic nerve head antigens. Graefes Arch Clin Exp Ophthalmol, 2005. 243(8): p. 817-23.
    • Hoffmann, E.M., et al., [Laser in situ keratomileusis (LASIK) and scanning laser ophthalmoscopy]. Ophthalmologe, 2005. 102(9): p. 856-62.
    • Hoffmann, E.M., et al., Scanning laser polarimetry and retinal thickness analysis before and after laser in situ keratomileusis. Eur J Ophthalmol, 2005. 15(4): p. 434-40.
    • Hoffmann, E.M., et al., Agreement among 3 optical imaging methods for the assessment of optic disc topography. Ophthalmology, 2005. 112(12): p. 2149-56.
    • Hoffmann, E., et al., Scanning laser polarimetry and retinal thickness analysis before and after laser in situ keratomileusis. Eur J Ophthalmol, 2005. 15(4): p. 434-440.
    • Grus, F.H., et al., SELDI-TOF-MS ProteinChip array profiling of tears from patients with dry eye. Invest Ophthalmol Vis Sci, 2005. 46(3): p. 863-76.
    • Grus, F.H., et al., Effects of multipurpose contact lens solutions on the protein composition of the tear film. Cont Lens Anterior Eye, 2005. 28(3): p. 103-12.

     

    2004

    • Troost, A., et al., [Agreement between clinical evaluation, Heidelberg-Retina-Tomograph (HRT) and Nerve Fiber Analyzer (GDx) in glaucoma diagnosis]. Klin Monbl Augenheilkd, 2004. 221(9): p. 757-61.
    • Singer, H.S., et al., Anti-basal ganglia antibodies in PANDAS. Mov Disord, 2004. 19(4): p. 406-15.
    • Hoffmann, E.M., F.H. Grus, and N. Pfeiffer, Intraocular pressure and ocular pulse amplitude using dynamic contour tonometry and contact lens tonometry. BMC Ophthalmol, 2004. 4: p. 4.
    • Grus, F.H., et al., Complex autoantibody repertoires in patients with glaucoma. Mol Vis, 2004. 10: p. 132-7.

     

    2003

    • Singer, H.S., et al., Anti-basal ganglia antibody abnormalities in Sydenham chorea. J Neuroimmunol, 2003. 136(1-2): p. 154-61.
    • Joachim, S.C., F.H. Grus, and N. Pfeiffer, Analysis of autoantibody repertoires in sera of patients with glaucoma. Eur J Ophthalmol, 2003. 13(9-10): p. 752-8.
    • Grus, F.H., S.C. Joachim, and N. Pfeiffer, Analysis of complex autoantibody repertoires by surface-enhanced laser desorption/ionization-time of flight mass spectrometry. Proteomics, 2003. 3(6): p. 957-61.
    • Grus, F.H., et al., Immunological effects of allopurinol in the treatment of experimental autoimmune uveitis (EAU) after onset of the disease. Eur J Ophthalmol, 2003. 13(2): p. 185-91.
    • Fust, A., et al., Changes in tear protein pattern after photorefractive keratectomy. Eur J Ophthalmol, 2003. 13(6): p. 525-31.

     

    2002

    • Schwenn, O., et al., Ocular pulse amplitude in patients with open angle glaucoma, normal tension glaucoma, and ocular hypertension. Br J Ophthalmol, 2002. 86(9): p. 981-4.
    • Herber, S., et al., Changes in the tear protein patterns of diabetic patients using two-dimensional electrophoresis. Adv Exp Med Biol, 2002. 506(Pt A): p. 623-6.
    • Grus, F.H., et al., Analysis of tear protein patterns for the diagnosis of dry eye. Adv Exp Med Biol, 2002. 506(Pt B): p. 1213-6.
    • Grus, F.H., et al., Changes in the tear proteins of diabetic patients. BMC Ophthalmol, 2002. 2: p. 4.
    • Grus, F.H., et al., Effect of smoking on tear proteins. Graefes Arch Clin Exp Ophthalmol, 2002. 240(11): p. 889-92.

     

    2001

    • Wendlandt, J.T., et al., Striatal antibodies in children with Tourette's syndrome: multivariate discriminant analysis of IgG repertoires. J Neuroimmunol, 2001. 119(1): p. 106-13.
    • Vogel, A., et al., [Reproducibility of measurement of ocular pulse amplitude and intraocular pressure using Smartlens]. Ophthalmologe, 2001. 98(10): p. 944-9.
    • Troost, R., et al., Clinical comparison of two intraocular pressure measurement methods: SmartLens dynamic observing tonography versus Goldmann. Graefes Arch Clin Exp Ophthalmol, 2001. 239(12): p. 889-92.
    • Herber, S., et al., Two-dimensional analysis of tear protein patterns of diabetic patients. Electrophoresis, 2001. 22(9): p. 1838-44.
    • Grus, F.H., P. Sabuncuo, and A.J. Augustin, [Quantitative analysis of tear protein profile for soft contact lenses--a clinical study]. Klin Monbl Augenheilkd, 2001. 218(4): p. 239-42.
    • Grus, F.H., P. Sabuncuo, and A.J. Augustin, Analysis of tear protein patterns of dry-eye patients using fluorescent staining dyes and two-dimensional quantification algorithms. Electrophoresis, 2001. 22(9): p. 1845-50.
    • Grus, F.H., et al., Analysis of the antibody repertoire in tears of dry-eye patients. Ophthalmologica, 2001. 215(6): p. 430-4.
    • Grus, F.H., et al., [From the genome to the proteome]. Ophthalmologe, 2001. 98(12): p. 1132-7.
    • Grus, F.H., et al., Allopurinol has immunomodulating activity following topical and systemic application in experimental autoimmune uveitis. Eur J Ophthalmol, 2001. 11(3): p. 252-60.
    • Grus, F.H. and A.J. Augustin, High performance liquid chromatography analysis of tear protein patterns in diabetic and non-diabetic dry-eye patients. Eur J Ophthalmol, 2001. 11(1): p. 19-24.
    • Frohn, A., et al., Late opacification of the foldable hydrophilic acrylic lens SC60B-OUV. Ophthalmology, 2001. 108(11): p. 1999-2004.
    • Dziewas, R., et al., Antibody pattern analysis in the Guillain-Barre syndrome and pathologic controls. J Neuroimmunol, 2001. 119(2): p. 287-96.

     

    2000

    • Grus, F.H., et al., [Immunological effect of systemically administered allopurinol in experimental autoimmune uveitis]. Klin Monbl Augenheilkd, 2000. 216(3): p. 165-71.
    • Grus, F.H. and A.J. Augustin, [Protein analysis methods in diagnosis of sicca syndrome]. Ophthalmologe, 2000. 97(1): p. 54-61.

     

    1999

    • Grus, F.H. and A.J. Augustin, Analysis of tear protein patterns by a neural network as a diagnostical tool for the detection of dry eyes. Electrophoresis, 1999. 20(4-5): p. 875-80.
    • Augustin, A.J., et al., Effects of systemically applied allopurinol and prednisolone on experimental autoimmune uveitis. Graefes Arch Clin Exp Ophthalmol, 1999. 237(6): p. 508-12.

     

    1998

    • Grus, F.H. and H. Stieve, Kinetics of rhodopsin regeneration in situ and in the excised median eye of Limulus polyphemus measured using electrophysiological methods. Pflugers Arch, 1998. 435(6): p. 827-33.
    • Grus, F.H., A.J. Augustin, and K. Toth-Sagi, Diagnostic classification of autoantibody repertoires in endocrine ophthalmopathy using an artificial neural network. Ocul Immunol Inflamm, 1998. 6(1): p. 43-50.
    • Grus, F.H., et al., Analysis of tear-protein patterns as a diagnostic tool for the detection of dry eyes. Eur J Ophthalmol, 1998. 8(2): p. 90-7.
    • Grus, F.H. and A.J. Augustin, Analysis of the IgG autoantibody repertoire in endocrine ophthalmopathy using the MegaBlot technique. Curr Eye Res, 1998. 17(6): p. 636-41.
    • Augustin, A.J., et al., Effects of perfluorooctylbromide and vitamin E on ischemia induced retinal oxidative tissue damage. Exp Eye Res, 1998. 66(1): p. 19-24.
    • Armstrong, D., et al., Detection of vascular endothelial growth factor and tumor necrosis factor alpha in epiretinal membranes of proliferative diabetic retinopathy, proliferative vitreoretinopathy and macular pucker. Ophthalmologica, 1998. 212(6): p. 410-4.

     

    1997

    • Grus, F.H. and C.W. Zimmermann, Identification and classification of autoantibody repertoires (Western blots) with a pattern recognition algorithm by an artificial neural network. Electrophoresis, 1997. 18(7): p. 1120-5.
    • Grus, F.H., et al., Immunomodulating activity of allopurinol in experimental lens-induced uveitis. Graefes Arch Clin Exp Ophthalmol, 1997. 235(2): p. 118-23.
    • Grus, F.H., A.J. Augustin, and C.W. Zimmermann, Computer-supported analysis (MegaBlot) of allopurinol-induced changes in the autoantibody repertoires of rats suffering from experimental lens-induced uveitis. Electrophoresis, 1997. 18(3-4): p. 516-9.
    • Augustin, A.J., et al., Detection of eicosanoids in epiretinal membranes of patients suffering from proliferative vitreoretinal diseases. Br J Ophthalmol, 1997. 81(1): p. 58-60.

     

    1996

    • Koch, F.H., et al., Effects of different antioxidants on lens-induced uveitis. Ger J Ophthalmol, 1996. 5(4): p. 185-8.
    • Blumenroder, S., et al., Retino-choroidal oxygen imaging through a fundus camera. Adv Exp Med Biol, 1996. 388: p. 35-9.
    • Augustin, A.J., et al., Effects of allopurinol and steroids on inflammation and oxidative tissue damage in experimental lens induced uveitis: a biochemical and morphological study. Br J Ophthalmol, 1996. 80(5): p. 451-7.
    • Augustin, A.J., F.H. Grus, and S. Hunt, Effects of allopurinol on free-radical-induced reduction of the proliferation of retinal pigment epithelial cells. Doc Ophthalmol, 1996. 93(3): p. 231-6.

     

    1995

    • Zimmermann, C.W., F.H. Grus, and R. Dux, Multivariate statistical comparison of autoantibody-repertoires (western blots) by discriminant analysis. Electrophoresis, 1995. 16(6): p. 941-7.
    • Breipohl, W., et al., Effects of UV-B on the growth pattern of bovine passage I and II lens epithelial cells in vitro. Ophthalmic Res, 1995. 27 Suppl 1: p. 62-8.
    • Augustin, A.J., et al., Indicators of oxidative tissue damage and inflammatory activity in epiretinal membranes of proliferative diabetic retinopathy, proliferative vitreoretinopathy and macular pucker. Ger J Ophthalmol, 1995. 4(1): p. 47-51.
    • Augustin, A.J., et al., Oxidative reactions in the tear fluid of patients suffering from dry eyes. Graefes Arch Clin Exp Ophthalmol, 1995. 233(11): p. 694-8.

     

    © 2015 Your Company. All Rights Reserved.